Christopher Saddler

11PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Multicultural education (excl. Aboriginal and Torres Strait Islander, Māori and Pacific Peoples)Cardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 22, 2026
Real World Utilization of Protocolized T-Cell Immunity Panel Screening in Cytomegalovirus Seropositive Kidney Transplant Recipients.

|Nov 19, 2025
Landscape of Current Transplant Infectious Disease Training Programs.

Michael J Scolarici, Jessica Tischendorf, Rachel Filipiak

|May 18, 2024
Infective endocarditis is rare in patients with hematologic malignancy and neutropenia.

Michael J Scolarici, Leigh R Berman, Natalie Callander

|Jul 03, 2022
Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomes.

Hanna L Kleiboeker, Margaret R Jorgenson, Glen E Leverson

|Nov 20, 2021
Letermovir conversion after valganciclovir treatment in cytomegalovirus high-risk abdominal solid organ transplant recipients may promote development of cytomegalovirus-specific cell mediated immunity.

Margaret R Jorgenson, Hanna Kleiboeker, Neetika Garg

|Jul 26, 2021
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients.

Margaret R Jorgenson, Jillian L Descourouez, Neetika Garg

Pageof 2